News | Press Releases

---

November 10, 2014

Safer Interventional Procedures with Enhancements to Toshiba’s Dose Tracking System

Clinicians See Radiation Exposure Like Never Before

TUSTIN, Calif., Nov. 10, 2014 – Measuring peak radiation skin dose during interventional procedures became a reality with Toshiba America Medical Systems, Inc.’s introduction of Dose Tracking System (DTS), which helps make exams safer for patients. To expand clinical applications, Toshiba is introducing enhancements to DTS for the entire Infinix™ product line, including the Elite, Select and Essential cardiovascular X-ray systems.

DTS now offers expanded bi-plane (frontal and lateral) coverage, increasing system utilization for neurovascular and congenital cardiology cases. The new version of DTS features specific patient head models that expand the ability to provide peak skin dose estimates to neurovascular procedures. An enhanced ability to track tilt and cradle movement of the table allows for additional expansion of capabilities in peak skin dose estimates. These new features help clinicians track and measure peak skin dose and help provide safer cardiovascular X-ray exams.

“DTS is a first-of-its-kind technology that improves patient safety and experience,” said David Sloop, director, X-ray Vascular Business Unit, Toshiba. “Understanding our customers’ business, we saw the opportunity to better serve them with these enhancements. Expanding the coverage and benefit of DTS across more applications gives customers the confidence that they are providing the safest, best approach to diagnoses and treatment.”

DTS will be showcased at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30–Dec. 5, 2014 (Booth 7333, North Hall).

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.

About Toshiba

Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical products and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in a safe, secure and comfortable society.

Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.

###